Carregant...
Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment
With the continued march of antimicrobial resistance, a renewed impetus for better vaccines has been heralded. Identification of potent subunit vaccines has been greatly facilitated by recent developments in reverse vaccinology and proteomics strategies. There are a range of antimicrobial resistant...
Guardat en:
| Publicat a: | Hum Vaccin Immunother |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215456/ https://ncbi.nlm.nih.gov/pubmed/27494532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1216287 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|